Clinical Trials Directory

Trials / Completed

CompletedNCT06428318

Diagnostic Value of the Biofire®in Community Acquired Pneumonia

Diagnostic Value of the Biofire® Filmarray Pneumonia Panel Compared to Conventional Sputum Culture in Critically il Patients With Pneumonia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aimed to determine the impact value of the BioFire FilmArray Pneumonia panel compared to conventional sputum culture in critically ill patients with pneumonia.

Detailed description

the BioFire® FilmArray Pneumonia Panel (BFPP) emerges as a promising candidate for a rapid and multifaceted diagnostic approach. This study compare the diagnostic accuracy, turnaround time, and impact on antibiotic management decisions of BFPP versus conventional sputum culture in critically ill patients admitted to the ICU with suspected pneumonia.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTConventional Sputum cultureSputum culture was done to patients and they received Antibiotics According to its results
DIAGNOSTIC_TESTBioFire Pneumonia Panel (BFPP)BioFire Pneumonia Panel (BFPP) was done to patients and they received Antibiotics According to its results

Timeline

Start date
2023-05-15
Primary completion
2024-04-30
Completion
2024-04-30
First posted
2024-05-24
Last updated
2024-05-29

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06428318. Inclusion in this directory is not an endorsement.